The Response Evaluation Criteria in Solid Tumors (RECIST) first introduced the use of one-dimensional measurements in 2000 9 and were recently revised (RECIST version 1.1). 10 Several studies have ...

Background: Response Assessment in Neuro-Oncology (RANO) criteria for high-grade and low-grade glioma (HGG and LGG) were developed to improve reliability of response assessment in glioma trials.

Cytokine release syndrome of grade 2 or higher (in 10% of patients) occurred just after the first infusion in this cohort; no events of cytokine release syndrome of grade 2 or higher were observed ...